Nektar's back pain opioid gets approval for FDA review

Drug Discovery |  News | 0 Comment | 30 Jul, 2018

 Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NKTR-181 for the treatment of chronic low back pain in adult patients n...Read more

Agios receives nod for ivosidenib

Drug Discovery |  News | 0 Comment | 23 Jul, 2018

Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (AML) with a sus...Read more

FDA approves Pfizer's biosimilar

Drug Discovery |  News | 0 Comment | 23 Jul, 2018

Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected to hit the market at a significant discount to its reference drug. Th...Read more

FDA approves first drug indicating treatment of smallpox

Drug Discovery |  News | 0 Comment | 16 Jul, 2018

 Singapore – The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Or...Read more

Immatics, Genmab to develop bispecific cancer immunotherapies

Drug Discovery |  News | 0 Comment | 12 Jul, 2018

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, has entered into a research c...Read more

FDA grants 7-year orphan drug exclusivity to Eagle

Drug Discovery |  News | 0 Comment | 09 Jul, 2018

Singapore – Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted seven years of orphan drug exclusivity (ODE) in the U.S., for BENDEKA (be...Read more

FDA grants ODD to OBI Pharma's lead investigational drug candidate

Drug Discovery |  News | 0 Comment | 09 Jul, 2018

OBI Pharma, a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for OBI-3424 for the Treatment of ...Read more

Biogen’s Alzheimer’s drug succeeds in trial

Drug Discovery |  News | 0 Comment | 06 Jul, 2018

Singapore – Eisai and Biogen have announced positive topline results from the Phase II study with BAN2401, an anti-amyloid beta protofibril antibody, in 856 patients with early A...Read more

Roche announces positive results of lung cancer drug Tecentriq

Drug Discovery |  News | 0 Comment | 04 Jul, 2018

Global pharma giant recently announced that its drug candidate for cancer- the combination of Tecentriq (atezolizumab) plus chemotherapy (Celgene’s Abraxane [albumin-bound paclitaxel;...Read more

Singapore institutes collaborate with ROK to develop innovative drugs

Drug Discovery |  News | 0 Comment | 03 Jul, 2018

Singapore – Scientists and clinicians from Singapore institutes are collaborating with C&C Research Laboratories, a leading research institute from the Republic of Korea...Read more

Lumicks teams up with AZ, UC to set up CoE

Drug Discovery |  News | 0 Comment | 28 Jun, 2018

LUMICKS, a world leader in dynamic single-molecule analysis, has partnered with AstraZeneca and the University of Cambridge Biochemistry Department to form the 'centre of Excellence for Dyn...Read more

Ascletis, CR Pharma sign strategic cooperation agreement

Drug Discovery |  News | 0 Comment | 27 Jun, 2018

Ascletis BioScience Co., Ltd. and CR Pharmaceutical Commercial Group Co., Ltd. have jointly announced that the two parties signed a strategic cooperation agreement in Beijing. The two parti...Read more

AUM Biosciences to drive commercial innovation in oncology

Drug Discovery |  News | 0 Comment | 25 Jun, 2018

Singapore - AUM Biosciences (AUM), a new company focused on the development of innovative and affordable oncology medicines with high unmet medical need in Asia, officially launched to...Read more

Mylan announces US launch of Bivalirudin for Injection

Drug Discovery |  News | 0 Comment | 19 Jun, 2018

Global pharmaceutical company Mylan has announced the US launch of Bivalirudin for Injection, 250 mg single-dose vial, a generic version of Angiomax from The Medicines Co...Read more

Ganovo approval marks a milestone for MAH policy in China

Drug Discovery |  News | 0 Comment | 14 Jun, 2018

Ascletis (partner of WuXi STA) receives approval from National Drug Administration of China (CNDA, former CFDA) of its Category 1 new drug, Ganovo® (also known as Danoprevir or ASC08), ...Read more

WuXi AppTec, Insilico unite to integrate AI with Drug Discovery

Drug Discovery |  News | 0 Comment | 12 Jun, 2018

Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of deep learning for target identification, drug discovery and aging rese...Read more

TESARO, Roche to evaluate triplet therapy for ovarian cancer

Drug Discovery |  News | 0 Comment | 06 Jun, 2018

Singapore-  TESARO, an oncology-focused biopharmaceutical company, announced that it has entered into a clinical collaboration with Genentech, a member of the Roche Group, to evaluate ...Read more

USFDA grants Priority Review to Astellas's NDA for Gilteritinib

Drug Discovery |  News | 0 Comment | 05 Jun, 2018

Japan’s Astellas Pharma recently announced that the U.S. Food and Drug Administration (FDA) has accepted, with Priority Review, the company's New Drug Application (NDA) for gilteritin...Read more